C: Use with caution if Added benefits outweigh risks. Animal experiments present hazard and human scientific studies not out there or neither animal nor human research completed. pentobarbital will minimize the extent or outcome of lonafarnib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Lonafarnib is a sensitive CYP3A4 substrate. Coadministration https://alfredm775kro6.homewikia.com/user